ESMO Congress 2024
ESMO Congress 2024
Advertisement
Rob DillardESMO Congress 2024 | December 3, 2024
Imaging modalities show significant efficacy in identifying metastasis among asymptomatic early-stage breast cancer.
Read More
Wungki Park, MD, MSPancreatic Cancer | September 27, 2024
Dr. Wungki Park gives an overview of the POLAR study for metastatic pancreatic cancer.
Wungki Park, MD, MSPancreatic Cancer | September 27, 2024
Dr. Wungki Park of Memorial Sloan Kettering Cancer Center discusses his trial on the use of ASP3082 for solid tumors.
Karine Tawagi, MDESMO Congress 2024 | December 3, 2024
Drs. Karine Tawagi and Adam Brufsky discuss exciting advancements and therapies on the horizon in the space of TNBC.
Karine Tawagi, MDESMO Congress 2024 | December 3, 2024
Dr. Adam Brufsky speaks with Dr. Adam Brufsky about the optimal therapeutic options to use in the TNBC patient population.
Karine Tawagi, MDESMO Congress 2024 | December 3, 2024
Drs. Karine Tawagi and Adam Brufsky discuss the biggest current challenges in the TNBC space.
Rob DillardESMO Congress 2024 | December 3, 2024
A multimodal deep learning prediction model demonstrated notable prognostic and therapeutic predictive value in TNBC.
Rob DillardESMO Congress 2024 | December 3, 2024
Advanced breast cancer in older patients is characterized by distinct molecular features.
Advertisement
Advertisement
Advertisement
Latest News

December 20, 2024